We consider sample size re-estimation in a clinical trial, in particular when there is a significant delay before the measurement of patient response. Mehta and Pocock have proposed methods in which sample size is increased when interim results fall in a 'promising zone' where it is deemed worthwhile to increase conditional power by adding more subjects. Our analysis reveals potential pitfalls ...
